Timofey Lebedev
Overview
Explore the profile of Timofey Lebedev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lebedev T, Mikheeva A, Gasca V, Spirin P, Prassolov V
Cells
. 2025 Mar;
14(5).
PMID: 40072065
Although every cell biologist knows the importance of selecting the right growth conditions and it is well known that the composition of growth medium may vary depending on a product...
2.
Kondakova I, Sereda E, Sidenko E, Vtorushin S, Vedernikova V, Burov A, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796785
Background: Proteasomes degrade intracellular proteins. Different proteasome forms were identified. Proteasome inhibitors are used in cancer therapy, and novel drugs directed to specific proteasome forms are developed. Breast cancer (BC)...
3.
Shulgin A, Spirin P, Lebedev T, Kravchenko A, Glasunov V, Yermak I, et al.
Heliyon
. 2024 Jul;
10(13):e33407.
PMID: 39050420
The efficiency of human immunodeficiency virus-1 (HIV-1) inhibition by sulfated polysaccharides isolated from the various families of red algae of the Far East Pacific coast were studied. The anti-HIV-1 activity...
4.
Burov A, Grigorieva E, Lebedev T, Vedernikova V, Popenko V, Astakhova T, et al.
Front Mol Biosci
. 2024 May;
11:1351641.
PMID: 38774235
Proteasomes are multi-subunit protein complexes responsible for protein degradation in cells. Immunoproteasomes and intermediate proteasomes (together non-constitutive proteasomes) are specific forms of proteasomes frequently associated with immune response, antigen presentation,...
5.
Glumakova K, Ivanov G, Vedernikova V, Shyrokova L, Lebedev T, Stomakhin A, et al.
Pharmaceutics
. 2023 Oct;
15(10).
PMID: 37896149
Nucleoside reverse transcriptase inhibitors are the first class of drugs to be approved by the FDA for the suppression of HIV-1 and are widely used for this purpose in combination...
6.
Kamashev D, Shaban N, Lebedev T, Prassolov V, Suntsova M, Raevskiy M, et al.
Cells
. 2023 Aug;
12(16).
PMID: 37626832
Regardless of the presence or absence of specific diagnostic mutations, many cancer patients fail to respond to EGFR-targeted therapeutics, and a personalized approach is needed to identify putative (non)responders. We...
7.
Lebedev T, Kousar R, Patrick B, Usama M, Lee M, Tan M, et al.
Cells
. 2023 Mar;
12(6).
PMID: 36980292
Epigenetic remodeling and metabolic reprogramming, two well-known cancer hallmarks, are highly intertwined. In addition to their abilities to confer cancer cell growth advantage, these alterations play a critical role in...
8.
Bondarev N, Ivanenko K, Khabusheva E, Lebedev T, Manukhov I, Prassolov V
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361596
Methionine dependence of malignant cells is one of the cancer hallmarks. It is well described that methionine deprivation drives cancer cells death, both in vitro and in vivo. Methionine gamma-lyase...
9.
Gu X, He M, Lebedev T, Lin C, Hua Z, Zheng Y, et al.
Biochem Biophys Rep
. 2022 Oct;
32:101364.
PMID: 36237442
Aberrant expression of protein arginine methyltransferases (PRMTs) has been implicated in a number of brain tumors, but the role of PRMT1 in medulloblastoma, the most common malignant pediatric brain tumor,...
10.
Spirin P, Shyrokova E, Vedernikova V, Lebedev T, Prassolov V
Cells
. 2022 Sep;
11(18).
PMID: 36139404
Chloroquine and Emetine are drugs used to treat human parasitic infections. In addition, it has been shown that these drugs have an antiviral effect. Both drugs were also found to...